DadFinStart your free week
DadFin › Stocks › Healthcare › LMRI

Lumexa Imaging Holdings, Inc. (LMRI) stock score

Healthcare · Medical Devices · United States

$10.54 ▲ +2.03% today

50.2
Dad Score, out of 100
middling

Lumexa Imaging Holdings, Inc. (LMRI) is a Medical Devices company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 50.2 out of 100 on the Dad Score, a middling reading that places the business ahead of 50% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #413 of 974. Its strongest axes are valuation, quality and growth; its weakest are price action and risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Above average
Growth
Above average
Price action
Weak
Risk
Below average
Conviction
Above average
Liquidity
Below average
Macro
Average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)11.5×
Dividend yield0.00%
Return on capital5.4%
Operating margin3.2%
Revenue growth (YoY)+7.8%
FCF yield-0.4%
Net debt / EBITDA11.59×
Piotroski F-Score8 / 9
52-week change-44.3%
Market cap$991M
Next earningsNov 12, 2026

What subscribers see on LMRI

Start your free weekSubscriber? Open the full research →

Medical Devices peers

StockCompanyDad ScoreBandMarket cap
ABTAbbott Laboratories78.9good$169.8B
MDTMedtronic plc90.4strong$110.5B
SYKStryker Corporation86.0strong$105.6B
BSXBoston Scientific Corporation94.3strong$61.7B
EWEdwards Lifesciences Corporation49.4middling$49.0B
DXCMDexCom, Inc.82.9good$32.2B
GEHCGE HealthCare Technologies Inc.94.5strong$29.2B
PHGKoninklijke Philips N.V.62.3middling$23.4B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.